Amgen To Present At The BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference

Amgen (NASDAQ: AMGN) will present at the BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference on June 23, 2020, at 4:00 p.m. ET.

Rhea-AI Summary

Amgen (NASDAQ: AMGN) will present at the BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference on June 23, 2020, at 4:00 p.m. ET. The presentation will be delivered by Elliott Levy, senior vice president of R&D Strategy and Operations. Interested parties can access a live audio stream through the Events Calendar on Amgen's website, with a replay available for 90 days post-event.

Amgen focuses on developing innovative therapies to address unmet medical needs, utilizing advanced human genetics to enhance health outcomes.

Argus Session date unavailable

+3.64% session move Open Argus

Details

News Market Reaction – AMGN

The recorded move for AMGN in the trading session of this news was +3.64%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

THOUSAND OAKS, Calif., June 18, 2020 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference at 4:00 p.m. ET on Tuesday, June 23, 2020. Elliott Levy, senior vice president of R&D Strategy and Operations at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for 90 days following the event.

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. 

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631 (media)
Arvind Sood, 805-447-1060 (investors) 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-bmo-capital-markets-2020-prescriptions-for-success-healthcare-conference-301079806.html

SOURCE Amgen

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the date and time of Amgen's presentation at the BMO conference?

Amgen will present at the BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference on June 23, 2020, at 4:00 p.m. ET.

Who will present for Amgen at the BMO conference?

Elliott Levy, senior vice president of R&D Strategy and Operations, will present for Amgen.

Where can I listen to Amgen's presentation live?

The live audio of Amgen's presentation can be accessed from the Events Calendar on Amgen's website.

Will there be a replay of Amgen's conference presentation?

Yes, a replay of the webcast will be available on Amgen's website for 90 days following the event.

What is Amgen's focus in biopharmaceuticals?

Amgen is focused on developing innovative human therapeutics to address serious illnesses and unmet medical needs.